Bosentan and dapagliflozin
( DrugBank: Bosentan, Dapagliflozin / KEGG DRUG: Bosentan, Bosentan, Dapagliflozin )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 40 | Takayasu arteritis | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 41 | Giant cell arteritis | 1 |
40. Takayasu arteritis
Clinical trials : 41 / Drugs : 66 - (DrugBank : 30) / Drug target genes : 35 - Drug target pathways : 126
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
41. Giant cell arteritis
Clinical trials : 160 / Drugs : 183 - (DrugBank : 35) / Drug target genes : 32 - Drug target pathways : 125
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|